May 23, 2017 / 8:46 AM / 6 months ago

BRIEF-UK's CMA issues statement of objections to Merck's unit

May 23 (Reuters) - UK’s Competition And Markets Authority:

* Issued a statement of objections to pharmaceutical company Merck Sharp & Dohme Limited (MSD)

* Provisionally found that MSD broke competition law by abusing its dominant position through a discount scheme for Remicade

* Sets out competition and markets authority’s provisional decision MSD operated anti-competitive discount scheme for its medicine Remicade

* “Proposes to find MSD and its ultimate parent company Merck & Co Inc jointly and severally liable for alleged infringement” Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below